The four principal gut epithelial cell lineages undergo continuous and rapid renewal during a geographically well-organized migration along the crypt-to-villus aids The crypt-to-villus axis of the mouse intestine represents a continuous developmental system. A multipotent stem cell, located near the base ofeach crypt, gives rise to descendants that undergo several amplifying rounds of cell division. Members of this proliferating, transit cell population are allocated to one of four principal lineages. These lineages complete their terminal differentiation programs during a rapid bipolar migration (1). Enterocytes, goblet, and enteroendocrine cells are translocated in vertical coherent bands from each monoclonal crypt to an adjacent villus and are subsequently exfoliated when they reach an extrusion zone located near the villus tip. Paneth cells differentiate as they are translocated to the base of each crypt where they are removed by phagocytosis. Proliferation, commitment, migration-associated differentiation, and exfoliation are completed rapidly-e.g., the turnover time for enterocytes, which compose 90-95% of gut epithelial cells, is =3 days (2).
However, coexpresson of SV40 TAgdell37 and [VaI2UKRAS does not produce dysplastic changes. Thus, the N-terminal 121 residues of TAg are sufficient to perturb the proliferative state of the enterocyte but not to produce detectable changes in the state of differentiation when coexpressed with [VaI12]KRAS.
The crypt-to-villus axis of the mouse intestine represents a continuous developmental system. A multipotent stem cell, located near the base ofeach crypt, gives rise to descendants that undergo several amplifying rounds of cell division. Members of this proliferating, transit cell population are allocated to one of four principal lineages. These lineages complete their terminal differentiation programs during a rapid bipolar migration (1) . Enterocytes, goblet, and enteroendocrine cells are translocated in vertical coherent bands from each monoclonal crypt to an adjacent villus and are subsequently exfoliated when they reach an extrusion zone located near the villus tip. Paneth cells differentiate as they are translocated to the base of each crypt where they are removed by phagocytosis. Proliferation, commitment, migration-associated differentiation, and exfoliation are completed rapidly-e.g., the turnover time for enterocytes, which compose 90-95% of gut epithelial cells, is =3 days (2) .
The factors that regulate proliferation and differentiation in the gut epithelium are largely unknown. The tumor suppressors p53 and the retinoblastoma susceptibility gene product (pRB) have been implicated in regulating passage through the G1/S checkpoint of the cell cycle. Mice homozygous for a Trp53 (transformation-telated protein p53 gene) null allele have no obvious abnormalities in intestinal morphology (3) . The effects of mutational inactivation ofRb-i on the intestine cannot be determined, since mice that are homozygous for Rb-i null alleles die before embryonic day 16 (E16)-i.e., prior to cytodifferentiation of the gut epithelium (1, 4, 5) . The large tumor antigen (TAg) of simian virus 40 (SV40) binds to and presumably disrupts the tumor suppressor functions of p53 and pRB. Binding to p53 requires two noncontiguous regions, which include residues 350-450 and 532-625. Res (6) (7) (8) (9) (10) . Expression of wild type (wt) and mutant SV40 TAgs in different cell lineages of transgenic mice represents one approach for defining the relative importance of p53, pRB, and related molecules in modulating their proliferation/differentiation programs (6) .
Promoter mapping studies conducted in transgenic mice have shown that nucleotides from -1178 to +28 ofthe rat gene encoding intestinal fatty acid binding protein (I-FABP) contain cis-acting sequences that restrict foreign gene expression to postmitotic enterocytes distributed along the length of duodenal, jejunal, and ileal villi (11) . I-FABp-1178 to +28/reporter transgenes are activated coincident with the initial cytodifferentiation of the gut epithelium (E15/E16), and expression is sustained throughout the first year of life. Studies of I-FABP-1178 to +28/SV40 TAgr transgenic mice have revealed that production ofthis viral oncoprotein in postmitotic enterocytes results in their reentry into the cell cycle (12, 13) . The nature of the cell cycle differs from that observed in crypts where the transgene is silent-i.e., S phase is longer in SV40 TAg-positive enterocytes and there may be a block at the G2/M boundary (12 
13).
Labelng Cells In S Phase and R al Dissection of the Intesine. Mice were maintained in microisolator cages and fed autoclaved Ralston Purina Chow (no. 5010) ad libitum.
All animals received an i.p. injection of BrdUrd (120 mg/kg of body weight) and 5-fluoro-2'-deoxyuridine (12 mg/kg) 1.5 hr prior to sacrifice at 5-47 weeks of age. The gastrointestinal tract was removed en bloc and subdivided into stomach (ST), duodenum (DU), proximal and distal jejunum (PJ,DJ), ileum (IL), cecum (CE), and proximal and distal colon (PC,DC) (11) . Samples (1 cm) were removed from each segment and placed in Bouin's solution. The remaining portions of each segment were frozen in liquid N2 as were the brain, heart, lung, liver, spleen, pancreas, kidney, and skeletal muscle.
Rbonulease rtecn Assays. SV40 TAg"r and SV40 TAg"'"37 mRNAs were detected as 125-nucleotide fragments when total cellular RNA was incubated with a 32P-labeled complementary RNA (cRNA) encompassing nucleotides 5023-4896 of SV40 TAg7' DNA. Human KRASVI'12 and mouse c-ras mRNAs were detected as 148 and 54 nucleotide ents, respectively, after hybridization to a 32P-labeled 199-nucleotide cRNA described in ref. 13 . Polyacrylamide gels containing the protected fagments were scanned with a radionuclide imager.
The intensity of the signal observed with tissue RNA was compared to the signals generated from known amounts of in vitro transcribed mRNA standards.
Mesurement of Steady-State Levels ofSV40 TAr' and SV40
TAew3. I-FABP-1178 to +28/SV40 TAg"' and I-FABP-1178 to +2s/SV40 TAgd"'137 transgenic mice were sacrificed at 8 and 47
weeks of age together with comparably aged nontransgenic littermates. The small intestine was removed en bloc and subdivided as described above. Each intestinal segment was frozen in liquid N2, pulverized, and Iyophilized. The lyophilized material was resuspended in an equal volume of extraction buffer containing 0.04 M Tris (pH 6.8), 2% 2-mercaptoethanol, 1% SDS, 5% glycerol, aprotinin at 1 pg/ml, leupeptin at 1 jig/ml, N-tosyl-L-phenylalanine chloro methyl ketone at 100 pg/mi, phenylmethylsulfonyl fluoride at 100 I g/ml, pepstatin A at 1 jpg/ml, and 1 Fig. 1A ). The mutant TAg retains the ability to complex cellular pRB and p107 but has lost the p53 binding domain as well as all known replicative functions. d11137 can transform some established cell lines (9) and induce choroid plexus tumors in transgenic mice (6) . Transformation of other established cell lines (9) or induction of B-and T-cell lymphomas in transgenic mice (6, 18) requires the p53 binding domain.
The two pedigrees of I-FABP-1178 lo +28/SV40 TAg transgenic mice used for this study were selected because the steady-state levels of their SV40 TAge and SV40 TAgd"137 mRNAs were similar along the duodenal-to-colonic axis at comparable ages ( Fig. 1 B, C , and E). Although immunocytochemical surveys using several polyclonal antibodies indicated that SV40 TAgw" is readily detectable in villusassociated enterocytes distributed from the base to the tips of duodenal,jejunal, and ileal villi, none of these antibodies was able to detect SV40 TAgM"'37, even under a wide variety of fixation conditions (data not shown). Therefore, Western blots were prepared containing total protein extracted from the duodenum, jejunum, and ileum of 8- Fig. 2 with Fig. 1C ).
I-FABP'1 +3/SV40 TAgd"'37 transgenic mice expressed a 15-kDa (but not a 90-kDa) immunoreactive protein that also showed similar regional variations in concentration along the cephalocaudal axis of their small intestine (lanes 6 and 7 in Fig. 2) . In any one segment of gut, the steady-state molar concentration of the mutant protein was 2-10 times higher than the wt protein (e.g., Fig. 2 ). The steady-state concentrations of wt and mutant TAg mRNA and protein within a given segment of gut did not change appreciably during the 10-month period surveyed (data not shown).
Evidence for expression of the mutant viral oncoprotein in villus-associated enterocytes was also provided by the observation that members of this cell lineage reenter the cell cycle (Fig. 3 A-C) . The distribution of BrdUrd-positive, S-phase cells follows the expression domain of I-FABP/SV40 TAgd""37 along the cephalocaudal axis of the gut-i.e., the number of enterocytes in S phase is greater in duodenal and jejunal villi than in ileal villi. The number of S-phase enterocytes overlying villi located at comparable positions of the duodenal-to-colonic axis is similar in 10-to 12-week-old I-FABP-1178 to +28/SV40 TAg"' and I-FABP-1178 to +28/SV40 TAgd"137 mice (n = 7-10). In each pedigree, the number of villus-associated cells in S phase exceeds the number of cells in M phase by several fold. SV40 TAg""'37-or SV40 TAg"'-induced reentry into the cell cycle is not associated with any detectable change in crypt-villus architecture, in the morphology of enterocytes, or in the patterns of expression of several markers of the enterocytic differentiation program (e.g., Fig.  3B ), even when mice are monitored for a period of6-7 months. These results indicate that post-mitotic, villus-associated enterocytes are capable of reentering the cell cycle and that activities contained in the N-terminal 121 residues of SV40 TAg are able to initiate their release from cell cycle arrest. Production of [Val'2JKRAS in villus-associated enterocytes has no demonstrable effect on proliferation or differentiation (13) . I-FABP-1178 to +28/SV40 TAg"' transgenic mice were mated to members of two pedigrees of I-FABP-1178 to +28/ KRASVa'12 mice. The steady-state levels and distribution of KRASvall2 mRNA along the duodenal-to-colonic axis are similar in members of these two KRA 1vall2 lines (13) (Fig.   lE) . The SV40 TAgwt x KRASVall2 bitransgenic mice exhibited marked dysplasia of their villus-associated enterocytes (Fig. 3 F and H) . Distortions in crypt-villus architecture were , Proc. Nati. Acad. Sci. USA 91 (1994) readily apparent and include polypoid structures as well as bifurcated and trifurcated villi (Fig. 3G) . Analysis of seven, 5-to 28-week-old mice indicated that these changes are evident in the duodenum, jejunum, and ileum at the earliest time-point surveyed, that they persist, and that they do not progress to adenomas or adenocarcinomas.
SV40 TAg"'137 mice were mated to members of the two KRASVal12 pedigrees to determine if amino acids (Fig. 1 C-E) . Despite these similarities in mRNA levels and the 2-to 10-fold higher steady-state levels of TAg'1137 versus TAge in small intestinal segments, the proliferative changes observed in SV40 TAgl'1137 x KRASvall2 bitransgenic mice (Fig. 3E) were less prominent than in comparably aged SV40 TAg"t x KRASVa1 ansrimals (Fig. 3D)- i.e., there were generally fewer enterocytes in S phase in duodenal, jejunal, or ileal villi. Moreover, the enterocytic dysplasia and distortions in crypt-villus architecture noted in seven 5-to 28-week-old SV40 TAg""/KRASVall2 transgenic mice (Fig. 3 GandH) were not evident in any of the six 5-to 12-week-old SV40 TAg"1137/ KJJ4Val12 mice examined (Fig. 3I) . This was true when either pedigree of I-FABP/KRASva1 mice was used to generate bitransgenic animals. These differences in enterocytic differentiation between SV40 TAgwt/KRASvall2 and SV40 TAgilll37/KRASVall2 transgenic mice were also reflected in the histopathologic scores oftheir proximal small intestine (1.9 ± 0.4 versus 0.7 ± 0.5, respectively; P = 0.005). No sigifant differences in histopathologic scores were noted in the distal half of their small intestine, where levels of transgene expression were lower (1.3 ± 0.5 versus 0.7 ± 0.5). Together, these findings indicate that the N-terminal 121 residues ofSV40 TAg contain elements that can lead to disruption of the cell cycle arrest in villus-associated enterocytes but do not contain the necessary activities required to support the dysplasia induced by coexpression of intact TAg and [Val2]KRAS. DISCUSSION One simple interpretation of the data presented in this study is that both SV40 TAgwt and the truncation mutant TAg'1137 allow postmitotic, villus-associated enterocytes to reenter the cell cycle because of their ability to interact with pRB, p107, and/or p300 and that TAg-mediated inactivation of p53 is not necessary to overcome their normal cell cycle arrest. In addition, the greater proliferative response observed when
[Vall2]KRAS is added to SV40 TAg"t-positive compared to SV40 TAgs'1137-positive enterocytes suggests that the role of p53 as a regulator of the cell cycle may be limited to members of this lineage, which contain aberrant signal transduction pathways. However, this interpretation remains quite speculative. For example, our transgenic mouse experiments cannot exclude the possibility that SV40 TAg activities other than p53 complex formation that reside in the C-terminal half of the molecule are responsible for mediating cooperative effects with [ValU2JKRAS, including both the proliferative and dysplastic responses of enterocytes. This latter hypothesis will have to be tested by comparing the intestinal epithelium of I-FABP/ KRASvall2 mice that are Trp53 -/-, -/+, and +/+ (3).
Analyses of regulation at the G1/S boundary in mammalian cells have been conducted in cultured cell lines. Little is known about the effects ofdifferentiation ofvanious mouse cell lineages in vivo on the levels of regulators of the G1/S boundary. The enterocyte's rapid progression from proliferation to cell cycle arrest and subsequent differentiation during a geographically well-organized (and perpetual) mgaton make it an attractive model for exploring this question. Moreover, the normally quiescent villus-associated enterocyte is a good target for gainof-function experiments. For example, E2F is a transcription factor that appears to regulate a number of genes that are activated in late G1, when cells are about to reenter S phase. Phosphorylation ofpRB is associated with release ofE2F from the pRB-E2F complex. SV40 TAg-mediated disruption of E2F's interaction with hypophosphorylated pRB could account forthe observed reentry ofenterocytes into S phase (19) . The potential roles of pRB and E2F in affecting the state of enterocytic proliferation along the crypt-to-villus axis could be tested by introducing SV40 TAg mutants that lack the pRB binding domain but retain p53 binding and trans-activation functions (6, 8) and/or by exa mice that contain an I-FABP-'1m to +28/E2F transgene. The assays for proliferative effects in enterocytes are straightforward as demonstrated in this report. producing, dysplastic enterocytes to undergo clonal expansion and progress to frank neoplasia is likely due to their rapid exfoliation (13) . Thus, these mice may also provide a sensitive assay system for identifying gene products that affect cellular translocation rates along the crypt-to-villus axis.
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